Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called ...
SPP1+ macrophages identified as key drivers and therapeutic targets in colorectal cancer progression
(B) Venn diagrams of common DEGs up- or down ... and immunosuppressive pathways. These macrophages interact with other cells through the SPP1-CD44, SPP1- PTGER4, and SPP1 a4b1 complex axes ...
Cardiovascular disease (CVD) is the leading cause of death and disease burden worldwide. Macrophages are important components of the internal immune cells, which profoundly affects the internal ...
Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study shows that blocking MARCO in ...
6d
News-Medical.Net on MSNTargeting MARCO enhances cancer immunotherapy effectivenessResearchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called ...
New injectable hydrogel regulates immune cell metabolism, reducing inflammation and slowing rheumatoid arthritis progression.
Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study, published ...
A research team from north China's Tianjin University has developed a new type of injectable hydrogel that can regulate ...
Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with ...
Asian News International on MSN16d
Scientists identify two types of heart scars, paving the way for targeted therapiesThe findings of what the Weizmann Institute researchers describe as "hot fibrosis" and "cold fibrosis" were recently published in the peer-reviewed journal Cell Systems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results